Interestingly, genomic analysis of HER2+ breast cancer revealed that DDX5 is adjacent to the WIP1-MIR21 amplicon and is co-amplified in 67% of HER2+ breast cancer with MIR21 amplification. The gene discussed is ERBB2; the disease is breast carcinoma.